Antibodies in autoimmune retinopathy

References

• Grange L, Dalal M, Nussenblatt RB, et al. Autoimmune retinopathy. Am J Ophthalmol. 2014 Feb;157(2):266–272.
   PubMed Web of Science ®Google Scholar
• Ferreyra HA, Jayasundera T, Khan NW, et al. Management of autoimmune retinopathies with immunosuppression. Arch Ophthalmol. 2009;127:390–397.
   PubMed Web of Science ®Google Scholar
• Sawyer RA, Selhorst JB, Zimmer LE, et al. Blindness caused by photoreceptor degeneration as a remote effect of cancer. Am J Ophthalmol. 1976;81:606–613.
   PubMed Web of Science ®Google Scholar
• Keltner JL, Roth AM, Chang RS. Photoreceptor degeneration; possible autoimmune disorder. Arch Ophthalmol. 1983 April;101(4):564–569.
   PubMedGoogle Scholar
• Klingele TG, Burde RM, Rappazzo JA, et al. Paraneoplastic retinopathy. J Clin Neuroophthalmol. 1984 Dec;4(4):239–245.
   PubMedGoogle Scholar
• Gass JD. Acute Vogt-Koyanagi-Harada-like syndrome occurring in a patient with metastatic cutaneous melanoma. Presented at: Proceedings of the First International Symposium on Uveitis; 1984; Amsterdam.
   Google Scholar
• Grunwald RB, Klein R, Simmonds MA, et al. Autoimmune basis for visual paraneopastic syndrome in patients with small-cell lung carcinoma. Lancet. 1985 Mar 23;1(8430):658–661.
   PubMed Web of Science ®Google Scholar
• Thirkill CE, Roth AM, Keitner JL. Cancer-associated retinopathy. Arch Ophthalmol. 1987;105:372.
   PubMedGoogle Scholar
• Thirkill CE, Tair RC, Tyler NK, et al. The cancer-associated retinopathy antigen is a recoverin-like protein. Invest Ophthalmol Vis Sci. 1992 Sep;33(10):2768–2772.
   PubMed Web of Science ®Google Scholar
• Adamus G, Aptsiauri N, Guy J, et al. The occurrence of serum autoantibodies against enolase in cancer-associated retinopathy. Clin Immunol Immunopathol. 1996 Feb;78(2):120–129.
   PubMedGoogle Scholar
• Adamus G, Brown L, Weleber RG. Molecular biomarkers for autoimmune retinopathies: significance of anti-transducin-alpha autoantibodies. Exp Mol Pathol. 2009 Dec;87(3):195–203.
   PubMed Web of Science ®Google Scholar
• Ohguro H, Ogawa K, Nakagawa T. Recoverin and Hsc 70 are found as autoantigens in patients with cancer-associated retinopathy. Invest Ophthalmol Vis Sci. 1999 Jan;40(1):82–89.
   PubMed Web of Science ®Google Scholar
• Kikuchi T, Arai J, Shibuki H, et al. Tubby-like protein 1 as an autoantigen in cancer-associated retinopathy. J Neuroimmunol. 2000 Feb 1;103(1):26–33.
   PubMed Web of Science ®Google Scholar
• Mizener JB, Kumura AE, Adamus G, et al. Autoimmune retinopathy in the absence of cancer. Am J Ophthalmol. 1997;123:607–618.
   PubMed Web of Science ®Google Scholar
• Heckenlively JR, Ferreyra HA. Autoimmune retinopathy: a review and summary. Semin Immunopathol. 2008 Apr;30(2):127–134.
   PubMed Web of Science ®Google Scholar
• Adamus G, Ren G, Weleber RG. Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy. BMC Ophthalmol. 2004 Jun;4(4):5.
   PubMedGoogle Scholar
• Adamus G. Autoantibody targets and their cancer relationship in the pathogenicity of paraneoplastic retinopathy. Autoimmun Rev. 2009 Mar;8(5):410–414.
   PubMed Web of Science ®Google Scholar
• Shildkrot Y, Sobrin L, Gragoudas ES. Cancer-associated retinopathy: update on pathogenesis and therapy. Semin Ophthalmol. 2011 Jul-Sep;26(4–5):321–328.
   PubMed Web of Science ®Google Scholar
• Goetgebuer G, Kestelyn-Stevens AM, De LaeyJJ, et al. Cancer-assocated retinopathy (CAR) with electronegative ERG: a case report. Doc Ophthalmol. 2008 Jan;116(1):49–550.
   PubMed Web of Science ®Google Scholar
• Abazari A, Allam SS, Adamus G, et al. Optical coherence tomography findings in autoimmune retinopathy. Am J Ophthalmol. 2012 April;153(4):750–756.
   PubMed Web of Science ®Google Scholar
• Lima LH, Greenberg JP, Greenstein VC, et al. Hyperautofluorescent ring in autoimmune retinopathy. Retina. 2012;32(7):1385–1394.
   PubMed Web of Science ®Google Scholar
• Rizzo FJ, Gittinger JW. Selective immunohistochemical staining in the paraneoplastic retinopathy syndrome. Ophthalmology. 1992 Aug;99(8):1286–1295.
   PubMed Web of Science ®Google Scholar
• McGinnis JF, Austin B, Klisak I. Chromosomal assignment of the human gene for the cancer-associated retinopathy protein (recoverin) to chromosome 17p13.1. J Neurosci Res. 1995 Feb 1;40(2):165–168.
   PubMed Web of Science ®Google Scholar
• Bazhin AV, Savchenko MS, Shifrina ON, et al. Recoverin as a paraneoplastic antigen in lung cancer: the occurrence of anti-recoverin autoantibodies in sera and recoverin in tumors. Lung Cancer. 2004 May;44(2):193–198.
   PubMed Web of Science ®Google Scholar
• Ohguro H, Odagiri H, Miyagawa Y, et al. Clinicopathological features of gastric cancer cases and aberrantly expressed recoverin. Tohoku J Exp Med. 2004;202(3):213–219.
   PubMed Web of Science ®Google Scholar
• Guy J, Aptsiauri N. Treatment of paraneoplastic visual loss with intravenous immunoglobulin: report of 3 cases. Arch Ophthalmol. 1999 Apr;117(4):471–477. Review
   PubMed Web of Science ®Google Scholar
• Harmon JP, Purvin VA, Guy J, et al. Cancer-associated retinopathy in a patient with advanced epithelial ovarian carcinoma. Gynecol Oncol. 1999 Jun;73:430–432.
   PubMed Web of Science ®Google Scholar
• Huober J, Holz FG, Schmid H, et al. Bastert G Paraneoplastic retinopathy in 2 patients with breast carcinoma. Zentralbl Gynakol. 1997;119:278–281.
   PubMedGoogle Scholar
• Adamus G, Amundson D, MacKay C, et al. Long-term persistence of antirecoverin antibodies in endometrial cancer-associated retinopathy. Arch Ophthalmol. 1998 Feb;116:251–253.
   PubMedGoogle Scholar
• Eltabbakh GH, Hoogerland DL, Kay MC. Paraneoplastic retinopathy associated with uterine sarcoma. Gynecol Oncol. 1995 July;58:120–123.
   PubMed Web of Science ®Google Scholar
• Yamada G, Ohguro H, Aketa K, et al. Invasive thymoma with paraneoplastic retinopathy. Hum Pathol. 2003 Jul;34(7):717–719.
   PubMed Web of Science ®Google Scholar
• Senin II, Koch KW, Akhtar M, et al. Ca2+-dependent control of rhodopsin phosphorylation: recoverin and rhodopsin kinase. Adv Exp Med Biol. 2002;514:69–99.
   PubMed Web of Science ®Google Scholar
• Adamus G, Webb S, Shiraga S, et al. Anti-recoverin antibodies induce an increase in intracellular calcium, leading to apoptosis in retinal cells. J Autoimmun. 2006 Mar;26(2):146–153.
   PubMed Web of Science ®Google Scholar
• Shiraga S, Adamus G. Mechanism of CAR syndrome: anti-recoverin antibodies are the inducers of retinal cell apoptotic death via the caspase 9 and caspase 3-dependent pathway. J Neuroimmunol. 2002 Nov;132(1–2):72–82.
   PubMed Web of Science ®Google Scholar
• Ohguro H, Maruyama I, Nakazawa M, et al. Antirecoverin antibody in the aqueous humor of a patient with cancer-associated retinopathy. Am J Ophthalmol. 2002 Oct;134(4):605–607.
   PubMed Web of Science ®Google Scholar
• Cao R, Xue Y, Hedlund EM, et al. VEGFR1-mediated pericyte ablation links VEGF and PIGF to cancer-associated retinopathy. Proc Natl Acad Sci USA. 2010 Jan 12;107(2):856–861.
   PubMed Web of Science ®Google Scholar
• Whitcup SM, Vistica BP, Milam AH, et al. Recoverin-associated retinopathy: a clinically and immunologically distinctive disease. Am J Ophthalmol. 1998 Aug;126(2):230–237.
   PubMed Web of Science ®Google Scholar
• Orth T, Kellner R, Diekmann O, et al. Meyer zum Buschenfelde KH, Mayet WJ: Identification and characterization of autoantibodies against catalase and alpha-enolase in patients with primary sclerosing cholangitis. Clin Exp Immunol. 1998 Jun;112:507–515.
   PubMed Web of Science ®Google Scholar
• Moodie FD, Leaker B, Cambridge G, et al. Segal AW: Alpha-enolase: a novel autoantigen in ANCA positive vasculitis. Kidney Int. 1993 Mar;43:675–68.
   PubMed Web of Science ®Google Scholar
• Tojo K, Tokuda T, Yazaki M, et al. Ikeda S-i: Paraneoplastic sensorimotor neuropathy and encephalopathy associated with anti-α-enolase antibody in a case of gastric adenocarcinoma. Eur Neurol. 2004;51:231–233.
   PubMed Web of Science ®Google Scholar
• Weleber RG, Watzke RC, Shults WT, et al. Clinical and electrophysiologic characterization of paraneoplastic and autoimmune retinopathies associated with antienolase antibodies. Am J Ophthalmol. 2005 May;139(5):780–794.
   PubMed Web of Science ®Google Scholar
• Magrys A, Anekonda T, Ren G, et al. The role of anti-alpha-enolase autoantibodies in pathogenicity of autoimmune-mediated retinopathy. J Clin Immunol. 2007 Mar;27(2):181–192.
   PubMed Web of Science ®Google Scholar
• Ridge KD, Palczewski K. Visual rhodopsin sees the light: structure and mechanism of G protein signaling. J Biol Chem. 2007;282(13):9297–9301.
   PubMed Web of Science ®Google Scholar
• Dryja TP, Hahn LB, Reboul T, et al. Missense mutation in the gene encoding the alpha subunit of rod transducing in the Nougaret form of congenital stationary night blindness. Nat Genet. 1996 Jul;13(3):358–360.
   PubMed Web of Science ®Google Scholar
• Piri N, Kwong JM, Gu L, et al. Heat shock proteins in the retina: focus on HSP70 and alpha crystallins in ganglion cell survival. Prog Retin Eye Res. 2016;52:22–46.
   PubMed Web of Science ®Google Scholar
• Spierings J, Van Eden W. Heat shock proteins and their immunomodulatory role in inflammatory arthritis. Rheumatology (Oxford). 2016 Jul 13. [Epub ahead of print].
   PubMedGoogle Scholar
• Lobo GP, Au A, Kiser PD, et al. Involvement of endoplasmic reticulum stress in TULP1 induced retinal degeneration. PLoS One. 2016 Mar 17;11(3):e0151806. doi:10.1371/journal.pone.0151806. eCollection 2016.
   Web of Science ®Google Scholar
• Ripps H, Carr RE, Siegel IM, et al. Functional abnormalities in vincristine-induced night blindness. Invest Ophthalmol Vis Sci. 1984;25:787–794.
   PubMed Web of Science ®Google Scholar
• Berson EL, Lessell S. Paraneoplastic night blindness with malignant melanoma. Am J Ophthalmol. 1988;106:307–331.
   PubMed Web of Science ®Google Scholar
• Alexander KR, Fishman GA, Peachey NS, et al. “On” response defect in paraneoplastic night blindness with cutaneous malignant melanoma. Invest Ophthalmol Vis Sci. 1992;33:477–483.
   PubMed Web of Science ®Google Scholar
• Milam AH, Saari JC, Jacobson SG, et al. Autoantibodies against retinal bipolar cells in cutaneous melanoma- associated retinopathy. Invest Ophthalmol Vis Sci. 1993;34:91–100.
   PubMed Web of Science ®Google Scholar
• Milam AH. Clinical aspects: paraneoplastic retinopathy. In: Djamgoz MBA, Archer SN, Vallerga S, eds. Neurobiology and clinical aspects of the outer retina. London: Chapman & Hall; 1995. p. 461–471.
   Google Scholar
• Keltner JL, Thirkill CE, Yip PT. Clinical and immunologic characteristics of melanoma-associated retinopathy syndrome: eleven new cases and a review of 51 previously published cases. J Neuroophthalmol. 2001;21:173–187.
   PubMed Web of Science ®Google Scholar
• Koh AH, Hogg CR, Holder GE. The incidence of negative ERG in clinical practice. Doc Ophthalmol. 2001 Jan;102(1):19–30.
   PubMedGoogle Scholar
• Lu Y, Jia L, He S, et al. Melanoma-associated retinopathy: a paraneoplastic autoimmune complication. Arch Ophthalmol. 2009;127:1572–1580.
   PubMedGoogle Scholar
• Nieuwendijk TJ, Hooymans JM. Paraneoplastic vitelliform retinopathy associated with metastatic choroidal melanoma. Eye (Lond). 2007;21:1436–1437.
   PubMed Web of Science ®Google Scholar
• Bianciotto C, Shields CL, Thirkill CE, et al. Paraneoplastic retinopathy with multiple detachments of the neurosensory retina and autoantibodies against interphotoreceptor retinoid binding protein (IRBP) in cutaneous melanoma. Br J Ophthalmol. 2010;94:1684–1685, 1696.
   PubMed Web of Science ®Google Scholar
• Dhingra A, Fina ME, Neinstein A, et al. Autoantibodies in melanoma-associated retinopathy target TRPM1 cation channels of retinal ON bipolar cells. J Neurosci. 2011;31:3962–3967.
   PubMed Web of Science ®Google Scholar
• McCall MA, Gregg RG. Comparisons of structural and functional abnormalities in mouse b-wave mutants. J Physiol. 2008 Sep 15;586(18):4385–4392.
   PubMed Web of Science ®Google Scholar
• Morgans CW, Zhang J, Jeffrey BG, et al. TRPM1 is required for the depolarizing light response in retinal ON-bipolar cells. Proc Natl Acad Sci USA. 2009 Nov 10;106(45):19174–19178.
   PubMed Web of Science ®Google Scholar
• Audo I, Kohl S, Leroy BP, et al. TRPM1 is mutated in patients with autosomal-recessive complete congenital stationary night blindness. Am J Hum Genet. 2009 Nov;85(5):720–729.
   PubMed Web of Science ®Google Scholar
• Duncan LM, Deeds J, Cronin FE, et al. Melastatin expression and prognosis in cutaneous malignant melanoma. J Clin Oncol. 2001 Jan 15;19(2):568–576.
   PubMed Web of Science ®Google Scholar
• Kondo M, Sanuki R, Ueno S, et al. Identification of autoantibodies against TRPM1 in patients with paraneoplastic retinopathy associated with ON bipolar cell dysfunction. PLoS One. 2011;6(5):e19911.
   PubMed Web of Science ®Google Scholar
• Wang Y, Abu-Asab MS, Li W, et al. Autoantibody against transient receptor potential M1 cation channels of retinal ON bipolar cells in paraneoplastic vitelliform retinopathy. BMC Ophthalmol. 2012;12:56.
   PubMed Web of Science ®Google Scholar
• Ukaji F, Kitajima I, Kubo T, et al. Serum samples of patients with rheumatoid arthritis contain a specific autoantibody to “denatured” aldolase A in the osteoblast-like cell line, MG-63. Ann Rheum Dis. 1999;58(3):169–174.
   PubMed Web of Science ®Google Scholar
• Arai Y, Kajihara S, Masuda J, et al. Position-independent, high-level, and correct regional expression of the rat aldolase C gene in the central nervous system of transgenic mice. Eur J Biochem. 1994;221(1):253–260.
   PubMedGoogle Scholar
• Caffé AR, Von Schantz M, Szél A, et al. Distribution of Purkinje cell–specific Zebrin-II/aldolase C immunoreactivity in the mouse, rat, rabbit, and human retina. J Comp Neurol. 1994;348(2):291–297.
   PubMed Web of Science ®Google Scholar
• Prasad R, Romsdahl MM, Shaw CR, et al. Isozyme variations in human malignant melanoma. Cancer Res. 1974;34(6):1435–1438.
   PubMed Web of Science ®Google Scholar
• Dawson WW, Jordan BL, Marsh RD, et al. Distant cancer effects on standardized testing of peripheral vision. Br J Ophthalmol. 2001;85:291–296.
   PubMed Web of Science ®Google Scholar
• Adamus G, Karren L. Autoimmunity against carbonic anhydrase II affects retinal cell functions in autoimmune retinopathy. J Autoimmun. 2009 Mar;32(2):133–139.
   PubMed Web of Science ®Google Scholar
• Forooghian F, Macdonald IM, Heckenlively JR, et al. The need for standardization of antiretinal antibody detection and measurement. Am J Ophthalmol. 2008 Oct;146(4):489–495.
   PubMed Web of Science ®Google Scholar
• Grewal DS, Fishman GA, Jampol LM. Autoimmune retinopathy and antiretinal antibodies: a review. Retina. 2014 May;34(5):827–845.
   PubMed Web of Science ®Google Scholar
• Faez S, Loewenstein J, Sobrin L. Concordance of antiretinal antibody testing results between laboratories in autoimmune retinopathy. JAMA Ophthalmol. 2013 Jan;131(1):113–115.
   PubMed Web of Science ®Google Scholar
• Keltner JL, Thirkill CE, Tyler NK, et al. Management and monitoring of cancer-associated retinopathy. Arch Ophthalmol. 1992;110(1):48–53.
   PubMedGoogle Scholar
• Espandar L, O’Brien S, Thirkill C, et al. Successful treatment of cancer-associated retinopathy with alemtuzumab. J Neurooncol. 2007;83(3):295–302.
   PubMed Web of Science ®Google Scholar
• Mahdi N, Faia LJ, Goodwin J, et al. A case of autoimmune retinopathy associated with thyroid carcinoma. Ocul Immunol Inflamm. 2010;18(4):322–323.
   PubMed Web of Science ®Google Scholar
• Fox AR, Gordon LK, Heckenlively JR, et al. Consensus on the diagnosis and management of nonparaneoplastic autoimmune retinopathy using a modified Delphi approach. Am J Ophthalmol. 2016 Aug;168:183–190.
   PubMed Web of Science ®Google Scholar
• Shimazaki K, Jirawuthiworavong GV, Heckenlively JR, et al. Frequency of anti-retinal antibodies in normal human serum. J Neuroophthalmol. 2008 Mar;28(1):5–11.
   PubMed Web of Science ®Google Scholar
• Adamus G, Ortega H, Witkowska D, et al. Recoverin: a potent uveitogen for the induction of photoreceptor degeneration in Lewis rats. Exp Eye Res. 1994 Oct;59(4):447–455.
   PubMed Web of Science ®Google Scholar
• Adamus G, Machnicki M, Elerding H, et al. Antibodies to recoverin induce apoptosis of photoreceptor and bipolar cells in vivo. J Autoimmun. 1998 Oct;11(5):523–533.
   PubMed Web of Science ®Google Scholar
• Maeda T, Maeda A, Maruyama I, et al. Mechanisms of photoreceptor cell death in cancer-associated retinopathy. Invest Ophthalmol Vis Sci. 2001;42:705–712.
   PubMed Web of Science ®Google Scholar
• Chen W, Elias RV, Cao W, et al. Anti-recoverin antibodies cause the apoptotic death of mammalian photoreceptor cells in vitro. J Neurosci Res. 1999;57:706–718.
   PubMed Web of Science ®Google Scholar
• Terrier B, Degand N, Guilpain P, et al. Alpha-enolase: a target of antibodies in infectious and autoimmune diseases. Autoimmun Rev. 2007;6(3):176–182.
   PubMed Web of Science ®Google Scholar
• Forooghian F. The uncertainty regarding antiretinal antibodies. JAMA Ophthalmol. 2015 Jul;133(7):744–745.
   PubMed Web of Science ®Google Scholar
• Adamus G, Wilson DJ. The need for standardization of antiretinal antibody detection and measurement. Am J Ophthalmol. 2009;147(3):557.
   PubMed Web of Science ®Google Scholar
• Braithwaite T, Vugler A, Tufail A. Autoimmune retinopathy. Ophthalmologica. 2012;228(3):131–142.
   PubMed Web of Science ®Google Scholar
• Forooghian F, Cao S, J C, et al. The enigma of autoimmune retinopathy. Int Ophthalmol Clin. 2015;55(2):81–91.
   PubMedGoogle Scholar
• Savchenko MS, Bazhin AV, Shifrina ON, et al. Antirecoverin autoantibodies in the patient with non-small cell lung cancer but without cancer-associated retinopathy. Lung Cancer. 2003;41:363–367.
   PubMed Web of Science ®Google Scholar
• Heckenlively JR, Jordan BL, Aptsiauri N. Association of antiretinal antibodies and cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol. 1999;127:565–573.
   PubMed Web of Science ®Google Scholar
• Chan CC, Palestine AG, Nussenblatt RB, et al. Anti-retinal auto-antibodies in Vogt-Koyanagi-Harada syndrome, Behçet’s disease, and sympathetic ophthalmia. Ophthalmology. 1985;92:1025–1028.
   PubMed Web of Science ®Google Scholar
• Whittle RM, Wallace GR, Whiston RA, et al. Human antiretinal antibodies in Toxoplasma retinochoroiditis. Br J Ophthalmol. 1998;82:1017–1021.
   PubMed Web of Science ®Google Scholar
• Chan CC, Nussenblatt RB, Kim MK, et al. Immunopathology of ocular onchocerciasis 2. Anti-retinal autoantibodies in serum and ocular fluids. Ophthalmology. 1987;94:439–443.
   PubMed Web of Science ®Google Scholar
• Ahn BY, Song ES, Cho YJ, et al. Identification of an anti-aldolase autoantibody as a diagnostic marker for diabetic retinopathy by immunoproteomic analysis. Proteomics. 2006;6:1200–1209.
   PubMed Web of Science ®Google Scholar
• Chen H, Wu L, Pan S, et al. An immunologic study on age-related macular degeneration. Yan Ke Xue Bao. 1993;9:113–120.
   PubMedGoogle Scholar